Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0V0VI
|
||||
Former ID |
DIB001795
|
||||
Drug Name |
11C-AZD-2184
|
||||
Synonyms |
AZD-2184-[11C]; AZD-2184-[3H]; Tritium-AZD-2184; Beta amyloid modulator (iv PET ligand, AD), AstraZeneca; Carbon-11-AZD-2184; Hydrogen-3-AZD-2184; Beta amyloid modulator (iv PET ligand, Alzheimer's disease), AstraZeneca; 3H-AZD-2184
|
||||
Indication | Alzheimer disease [ICD9: 331; ICD10:G30] | Phase 1 | [522574] | ||
Company |
AstraZeneca plc
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
c1(ccc2c(c1)sc(n2)c1cnc(cc1)N[11CH3])O
|
||||
Target and Pathway | |||||
Target(s) | Amyloid beta A4 protein | Target Info | Binder | [544299] | |
KEGG Pathway | Notch signaling pathway | ||||
Alzheimer's disease | |||||
Reactome | Nuclear signaling by ERBB4 | ||||
Degradation of the extracellular matrix | |||||
Regulated proteolysis of p75NTR | |||||
NRIF signals cell death from the nucleus | |||||
Activated NOTCH1 Transmits Signal to the Nucleus | |||||
Constitutive Signaling by NOTCH1 PEST Domain Mutants | |||||
Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | |||||
EPH-ephrin mediated repulsion of cells | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.